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ABSTRACT
Objectives Roux-en-Y gastric bypass (RYGB) has
greater efﬁcacy for weight loss in obese patients than
gastric banding (BAND) surgery. We hypothesise that
this may result from different effects on food hedonics
via physiological changes secondary to distinct gut
anatomy manipulations.
Design We used functional MRI, eating behaviour and
hormonal phenotyping to compare body mass index
(BMI)-matched unoperated controls and patients after
RYGB and BAND surgery for obesity.
Results Obese patients after RYGB had lower brain-
hedonic responses to food than patients after BAND
surgery. RYGB patients had lower activation than BAND
patients in brain reward systems, particularly to high-
calorie foods, including the orbitofrontal cortex,
amygdala, caudate nucleus, nucleus accumbens and
hippocampus. This was associated with lower palatability
and appeal of high-calorie foods and healthier eating
behaviour, including less fat intake, in RYGB compared
with BAND patients and/or BMI-matched unoperated
controls. These differences were not explicable by
differences in hunger or psychological traits between the
surgical groups, but anorexigenic plasma gut hormones
(GLP-1 and PYY), plasma bile acids and symptoms of
dumping syndrome were increased in RYGB patients.
Conclusions The identiﬁcation of these differences in
food hedonic responses as a result of altered gut
anatomy/physiology provides a novel explanation for the
more favourable long-term weight loss seen after RYGB
than after BAND surgery, highlighting the importance of
the gut–brain axis in the control of reward-based eating
behaviour.
INTRODUCTION
Bariatric surgery is currently the most effective long-
term treatment for obesity and its associated
comorbidities.1 Over 20 years, Roux-en-Y gastric
bypass (RYGB) surgery achieves on average 25%
weight loss compared with 14% with gastric banding
(BAND) surgery.1 This suggests that the speciﬁc ana-
tomical manipulations of the gut in each procedure
may have very different physiological effects.2
In RYGB, the formation of a small gastric pouch
enables food to have earlier contact with the mid
and distal small bowel. Food bypasses the stomach
and proximal small bowel, but undiluted bile has
contact with the proximal small bowel. Vagal ﬁbres
across the stomach may be disrupted.3 4 Reduced
hunger and increased satiety after RYGB are in part
due to early and exaggerated responses of
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Signiﬁcance of this study
What is already known about this subject?
▸ Bariatric surgery is the most effective long-term
treatment for obesity.
▸ Gastric bypass surgery results in more weight
loss than gastric banding surgery.
▸ Gastric bypass, but not gastric banding surgery,
leads to increased postprandial anorexigenic
gut hormones.
▸ Gastric bypass surgery patients report a shift in
food preference that is away from high-calorie
foods.
What are the new ﬁndings?
▸ Using functional MRI, activation in brain
reward systems, including orbitofrontal cortex,
amygdala, putamen, caudate and nucleus
accumbens, during evaluation of the appeal of
high-calorie food pictures was less after gastric
bypass than after gastric banding surgery.
▸ High-calorie foods were less appealing and
consumed less after gastric bypass than gastric
banding surgery.
▸ These differences were not explicable by
differences in hunger levels or psychological
traits.
▸ Plasma GLP-1, PYY, bile acids and postingestive
dumping symptoms were higher after gastric
bypass than gastric banding surgery.
How might it impact on clinical practice in
the foreseeable future?
▸ A more personalised approach to the choice of
bariatric procedure including assessment of
food hedonics may be warranted.
▸ Targeting the gut–brain food hedonic axis is
important in the development of future
non-surgical treatments of obesity.
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anorexigenic intestinal hormones, such as peptide YY (PYY) and
glucagon-like polypeptide-1 (GLP-1), part of the gut–brain axis
regulating ingestive behaviour.5 These gut hormone changes are
absent after BAND surgery, where the adjustable band around
the proximal stomach reduces hunger through increased intra-
luminal pressure on vagal afferent mechanoreceptors.6
Human eating behaviour is affected by hunger, and also by
the reward value of food.7 An advantageous shift away from
consumption of high-fat and sweet food after RYGB surgery has
been reported in animal and human studies.7–9 However, differ-
ences in food hedonics between RYGB and BAND surgery, the
two most commonly performed procedures around the world,
and their underlying neural basis, have not been explored.
Functional MRI (fMRI) allows study of brain reward-
cognitive systems related to eating behaviour by measuring
regional changes in the blood oxygen level-dependent (BOLD)
signal to food stimuli, a marker of neuronal activation.10 These
include corticolimbic networks: striatal nucleus accumbens and
caudate nucleus (reward conditioning, expectancy, motivation
and habitual behaviour), amygdala (emotional responses to
rewarding stimuli), anterior insula (integrating gustatory and
other sensory information) and orbitofrontal cortex (OFC)
(encoding of reward value and salience, decision making).11 12
We hypothesised that RYGB and BAND procedures have dif-
ferent effects on brain reward systems, and hence, on eating
behaviour, which may explain the greater weight loss seen after
RYGB. We compared body mass index (BMI)-matched patients
after RYGB and BAND surgery, with BMI-matched unoperated
controls that had not lost weight. The primary outcome
measure was reward system activation to food pictures using
fMRI, and secondary outcomes were behavioural and metabolic
phenotyping measures.
METHODS
Further details are given in online supplementary methods.
Participants
Eighty-three participants (30 RYGB, 28 BAND, 25
BMI-matched (BMI-M) unoperated controls) were recruited
from obesity clinics and public advertisement. Surgical patients
were recruited more than 2 months after surgery, after losing at
least 8% body weight (see online supplementary table S1).
Unoperated BMI-matched controls were weight stable. Of these,
61 participants (21 RYGB, 20 BAND, 20 BMI-M) were eligible
for a scanning visit (table 1). fMRI scans of two subjects (1
RYGB, 1 BMI-M) were excluded from analysis due to excess
motion and/or poor image quality. For inclusion and exclusion
criteria see online supplementary methods.
Psychological and eating behaviour phenotyping
All subjects completed questionnaires to assess eating behaviour,
mood, impulsivity, personality and reward sensitivity.
fMRI protocol
Eligible subjects had structural MRI and BOLD fMRI for 1 h
after an overnight fast (ﬁgure 1). During a food picture evalu-
ation task, subjects viewed photographs of high-calorie foods,
low-calorie foods, non–food-related household objects and
blurred images.13 Subjects simultaneously rated the appeal of
each picture. An auditory–motor–visual control fMRI task was
performed to exclude non-speciﬁc changes in BOLD signal
between groups.
fMRI analysis
fMRI data processing used the fMRI Expert Analysis Tool
V.5.98 (http://www.fmrib.ox.ac.uk/fsl). General linear model
analysis was used to measure BOLD activation to (i) any food
(high-calorie or low-calorie); (ii) only high-calorie foods or (iii)
only low-calorie foods (compared with objects) in the food
evaluation task; and for (iv) auditory, motor or visual tasks in
the control paradigm.
Table 1 Characteristics of obese patients after gastric bypass and gastric banding and unoperated controls at time of fMRI scanning
BMI-M BAND RYGB p Values*
n 20 20 21
Age (years) 39.1±2.3 (20.0–55.0) 40.9±2.5 (22.0–59.0) 43.5±2.0 (23.0–59.0) 0.38
Gender (Male:Female) 3 : 17 1 : 19 4 : 26 0.57
Postmenopausal women, n (%) 5 (25%) 5 (25%) 6 (29%) 0.96
Ethnicity: European Caucasians, n (%) 10 (50%) 15 (75%) 16 (76%) 0.14
Preoperative BMI (kg/m2) n/a 44.8 [41.9–49.2] (36.5–57.0) 48.4 [40.7–58.0] (34.7–74.6) 0.23
Current BMI (kg/m2) 35.4±1.9 (24.7–55.6) 35.1±1.4 (25.3–49.2) 35.3±1.7 (22.6–52.4) 0.99
Current height (m) 1.64±0.02 (1.49–1.78) 1.66±0.02 (1.53–1.79) 1.66±0.02 (1.52–1.85) 0.64
Current weight (kg) 97.0±3.1 (73.9–119.8) 97.0±3.1 (73.9–119.8) 98.1±4.9 (63.7–137.9) 0.97
Current body fat (%) 42.1±2.2 (26.0–58.2) 41.9±1.8 (23.3–54.7) 41.3±1.9 (28.4–56.0) 0.96
Weight loss (% of preoperative weight) n/a 23.1 [14.5–29.3] (9.7–52.4) 29.9 [23.4–36.5] (16.3–40.4) 0.018
RYGB > BAND
Time since surgery (months) n/a 9.1 [5.2–19.2] (3.6–64.6) 8.1 [5.9–11.5] (2.6–26.2) 0.25
Preoperative DM, n (%) n/a 2 (10%) 10 (48%) 0.02
RYGB > BAND
Current DM, n (%) 2 (10%) 0 (0%) 3 (14%) 0.23
Preoperative obesity comorbidity score n/a 6.0 [4.5–6.0] (1.0–10.0) 10.0 [6.6–11.5] (3.0–19.0) <0.001
RYGB > BAND
Current obesity comorbidity score 0.0 [0.0–5.0] (0.0–18.0) 0.0 [0.5–2.0] (0.0–9.0) 1.0 [0.8–3.0] (0.0–10.0) 0.85
Preoperative BED, n (%) n/a 4 (25%) 4 (19%) 1.00
Current BED, n (%) 2 (10%) 2 (10%) 1 (5%) 0.78
Data included only for those subjects who had fMRI scanning. Data presented as mean±SEM or median [IQR] for data that are not normally distributed and (range).
*p Value for overall comparison between groups.
BAND, gastric banding; BED, binge eating disorder; BMI, body mass index; BMI-M, BMI-matched; DM, type 2 diabetes mellitus; n/a, not applicable; RYGB, gastric bypass.
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Whole brain mixed effects analysis compared BOLD signal
between surgical groups using unpaired t test, with both voxel-
wise false discovery rate (FDR) corrected p<0.05 and cluster-
wise threshold Z>2.1, familywise error corrected p<0.05,
including age, gender and BMI as covariates. Activation in a
priori functional regions of interest (fROIs) was compared
between all groups for the food evaluation task using the fol-
lowing ROIs (see online supplementary ﬁgure S1 and table S4):
bilateral OFC, amygdala, nucleus accumbens, anterior insula
and caudate nucleus. These fROIs were determined from a sep-
arate cohort of 24 overweight/obese subjects who had the same
fMRI protocol (see online supplementary tables S2 and S3).
The anatomically constrained functional ROIs were deﬁned by
masking average activation for the food > object contrast
(voxel-wise FDR, p<0.05) with the Harvard anatomical atlas
(see online supplementary methods). fROIs for the control para-
digm were bilateral superior posterior temporal gyrus (audi-
tory), left precentral gyrus (motor) and bilateral lingual gyrus
(visual) (see online supplementary ﬁgure S2A and table S4).
Appetite and food palatability
Visual analogue scales (VAS) were used to measure appetite
ratings, lunch palatability and other confounding symptoms
(ﬁgure 1). Scanning was followed by an ad libitum ice cream
test meal for the two surgical groups.
Dietary habits
Diet macronutrient composition was assessed using 3-day self-
reported home dietary records in the two surgical groups, ana-
lysed using Dietplan6 (Foresﬁeld Software Ltd, West Sussex, UK).
Hormonal and metabolic phenotyping
Serial blood samples before and after scanning were collected for
measurement of plasma glucose, insulin, gut hormones (PYY, GLP-1
and acyl ghrelin) and bile acids (see online supplementary ﬁgure S1).
Dumping syndrome
Symptoms and signs of dumping syndrome in the surgical
groups were assessed from postprandial changes in nausea,
sleepiness, blood pressure and heart rate and retrospective com-
pletion of validated questionnaires (Sigstad’s and Arts’) for the
3 months following surgery.
Statistical analysis
Results are presented as mean±SEM or median [IQR] for data that
were not normally distributed. Comparisons of averages between
groups used unpaired t tests or one-way analysis of variance
(ANOVA) with post hoc Fisher’s least signiﬁcant difference test or,
if not normally disturbed, Mann–Whitney U test or Kruskal–Wallis
ANOVA on Ranks with post hoc Dunn’s test. Comparison of
prevalence between groups used χ2 test. Comparisons between
groups for fMRI activation and eating behaviour and psychological
questionnaires were adjusted for age, gender and BMI. To further
investigate the link between brain responses to food cues, food
hedonics and potential mediators, correlations between BOLD acti-
vation (adjusted for age, gender and BMI) and ice cream palatabil-
ity or gut hormones/bile acids/dumping syndrome scores were
performed to determine Pearson, or if not normally distributed
Spearman, correlation coefﬁcients. Signiﬁcance was taken as
p<0.05. Analyses used SPSS V.19.0 and Prism V.5.01.
RESULTS
Participant characteristics
There were no signiﬁcant differences between the groups in age,
gender ratio, prevalence of postmenopausal women, ethnicity,
current BMI, percentage body fat, prevalence of type 2 diabetes
mellitus (T2DM) or binge eating disorder (BED), for both the
whole cohort (see online supplementary table S1) and the
scanned subjects only (table 1). The two surgical groups had
similar preoperative BMI and prevalence of BED. The RYGB
group had more obesity-associated comorbidities preoperatively,
Figure 1 Study protocol. AMV, audio–motor–visual task; BAND, gastric banding; BP, blood pressure; fMRI, functional MRI; RYGB, gastric bypass;
VAS, visual analogue scales.
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but not postoperatively, compared with the BAND group. There
were no signiﬁcant differences between the groups in any psy-
chological questionnaire measures of depression, mood, reward
sensitivity, impulsivity or personality traits (see online supple-
mentary table S5).
Brain activation to food pictures
In whole brain analysis, there was lower BOLD activation in the
RYGB group compared with the BAND group when viewing
high-calorie foods in clusters within the OFC, subcallosal
cortex, putamen, caudate, nucleus accumbens, hippocampus,
cingulate and paracingulate gyri (ﬁgure 2, see online supplemen-
tary table S6). BOLD activation when viewing low-calorie foods
was also lower in the OFC and subcallosal cortex in the RYGB
group than in the BAND group. By contrast, there were no clus-
ters with greater BOLD activation in the RYGB group compared
with the BAND group when viewing high-calorie or low-calorie
foods (see online supplementary table S6).
In the functional region of interest (fROI) analysis, BOLD acti-
vation within the whole reward system (average activation in the
OFC, amygdala, anterior insula, nucleus accumbens and caudate)
was lower in the RYGB group compared with the BAND group
when viewing high-calorie, but not low-calorie, foods (ﬁgure 3A
and see online supplementary ﬁgure S1, tables S4 and S7).
When examining individual fROIs, BOLD activation in the
OFC and amygdala was lower in the RYGB group compared
with the BAND group, and for amygdala also the control
BMI-M group, when viewing any food (ﬁgure 3B,C and see
online supplementary table S7). Similar patterns were seen for
high-calorie and low-calorie foods.
There were no differences in BOLD activation of the other
fROIs in the food evaluation task (ﬁgure 3D–F, see online
supplementary table S7). There were also no differences in
BOLD activation in the auditory, motor or visual cortices for
the auditory–visual–motor control fMRI task between the three
groups in either the whole brain or fROI analysis (see online
supplementary ﬁgure S2A,B, tables S4 and S7).
Food appeal scores
During scanning, high-calorie foods, but not low-calorie foods
or objects, were rated as less appealing by patients after RYGB
than those after BAND surgery and control BMI-M subjects
(ﬁgure 4A,B).
Appetite VAS
Over the scanning period both the RYGB and BAND groups rated
their ‘hunger’, ‘pleasantness to eat’ and ‘volume of food they
could eat’ as lower than the control group, but there was no differ-
ence between the two surgical groups (ﬁgure 5A,E,G). RYGB
patients were also less nauseated than BAND patients before the
test meal, but absolute nausea ratings were still low (ﬁgure 5C).
After scanning, during a test meal, patients after RYGB and
BAND surgery consumed similar amounts of ice cream (p=0.54),
but patients after RYGB rated it as less ‘pleasant to eat’ than
Figure 2 Whole brain comparison of activation to high-calorie foods between obese patients after gastric bypass and gastric banding. Whole brain
group level comparison for high-calorie versus object picture contrast to demonstrate clusters in which blood oxygen level-dependent (BOLD) signal
was lower in patients after gastric bypass (RYGB) compared with gastric banding (BAND) surgery, adjusting for age, gender and body mass index.
No clusters showed greater activation in RYGB than BAND groups. Colour bar indicates Z values. Cluster activation thresholded at Z>2.1, familywise
error p<0.05, overlaid onto the average T1 scan for all subjects (n=20 per group). Co-ordinates given in standard Montreal Neurological Institute
(MNI) space. ACC: anterior cingulate cortex, Amy: amygdala, Caud: caudate, NAcc: nucleus accumbens, Hipp: hippocampus, MFG: middle frontal
gyrus, OFC: orbitofrontal cortex, Put: putamen. Voxel-wise differences in BOLD activation between groups did not survive false discovery rate p<0.05
correction.
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those after BAND (p=0.047), but similarly sweet (p=0.96)
(ﬁgure 4C,D). The two surgical groups had similar decreases in
hunger and increases in fullness after the meal (ﬁgure 5B,J).
Dietary records
Analysis of home food diaries showed that the percentage of
energy intake derived from fat was lower in patients after RYGB
than after BAND surgery (ﬁgure 4E).
Eating behaviour assessment
In the whole cohort, eating behaviour questionnaires indicated
that patients after RYGB had healthier eating behaviour and less
eating disorder psychopathology compared with the BAND and/
or control groups, with signiﬁcantly lower scores for dietary
restraint, external eating and weight and shape concerns (ﬁgure 6).
Metabolic and hormonal phenotyping
Plasma GLP-1 levels were similar between the three groups during
scanning, but increased signiﬁcantly more in the RYGB group than
Figure 3 Region of interest activation to food in obese patients after gastric bypass and gastric banding and unoperated controls. Comparison of
blood oxygen level-dependent (BOLD) signal to any food, only high-calorie or only low-calorie food (vs objects) in a priori functional regions of
interest (fROI) between body mass index-matched unoperated controls (BMI-M, white), and obese patients after gastric banding (BAND, dotted) and
gastric bypass (RYGB, striped) surgery, adjusting for age, gender and BMI. (A) Average in all ﬁve fROIs, (B) orbitofrontal cortex, (C) amygdala, (D)
anterior insula, (E) nucleus accumbens, (F) caudate. Data are presented as mean±SEM. #p<0.05, ##p<0.01, ###p<0.005 versus BMI-M; *p<0.05,
**p<0.01, ***p<0.005 versus BAND; n=19–20 per group.
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in the BAND group after the meal (ﬁgure 7A,B). Plasma PYY
levels during scanning were higher in the RYGB group than in
the BMI-M group, and increased more in the RYGB group than in
the BAND group after the meal (ﬁgure 7C,D). There were
no differences in plasma acyl ghrelin levels between the groups
(ﬁgure 7E,F).
Plasma levels of total and glycine conjugated bile acids were
higher in RYGB than BAND groups both during scanning and
after the meal (ﬁgure 7G,H, see online supplementary ﬁgure
S3A,B). The subfractions of primary and deoxycholic bile acids
were higher in the RYGB patients than the BAND patients only
after the meal (see online supplementary ﬁgure S3C–F).
Plasma glucose and insulin levels during the scanning period
did not differ between the two surgical groups (see online sup-
plementary ﬁgure S3G,I). Glucose levels increased more after
the meal in the RYGB group compared with the BAND group
(see online supplementary ﬁgure S3H), but there were similar
increases in insulin levels (see online supplementary ﬁgure S3J).
Dumping symptoms and signs
Both retrospective dumping symptom questionnaire scores were
higher for the patients after RYGB than after BAND surgery
(ﬁgure 8). The RYGB group had a greater increase in symptoms of
‘feeling sick’ than the BAND group after the meal (ﬁgure 5D, see
Figure 4 Food hedonics and dietary composition in obese patients after gastric bypass and gastric banding. Comparison of (A) appeal of any
food, only high-calorie or only low-calorie food pictures; (B) appeal of subcategories of high-calorie food pictures; (C) ice cream consumption and
(D) ice cream palatability rating at meal after fMRI scan; and (E) average percentage of total calories from fat from 3 day food diary, between body
mass index-matched unoperated controls (BMI-M, white) and obese patients after gastric banding (BAND, dotted) and gastric bypass (RYGB, striped)
surgery. Data are presented as mean±SEM. #p<0.05, ###p<0.005 versus BMI-M; *p<0.05, ***p<0.005 versus BAND; n=20–21 per group.
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online supplementary table S8), but there were no differences in
the change in blood pressure or heart rate after the meal between
the surgical groups (see online supplementary table S8).
Confounding variables
There were no signiﬁcant differences between the groups in
potential confounding factors known to affect BOLD activation
to food cues or non-speciﬁcally, including sleepiness, mood,
sleep duration, time since last meal or head motion during scan-
ning (see online supplementary table S10).
Correlation between outcome measures
BOLD activation to high-calorie food pictures in the whole
reward system was positively correlated with VAS pleasantness
Figure 5 Appetite visual analogue
scales during fMRI and after meal.
Comparison of visual analogue scale
ratings of (A and B) hunger, (C and D)
nausea, (E and F) pleasantness to eat,
(G and H) volume of food that could
be eaten and (I and J) fullness. (A,C,E,
G and I) Levels during fMRI scanning
(area under curve (AUC) +40 to
+150 min) between body mass
index-matched unoperated controls
(BMI-M, white) and obese patients
after gastric banding (BAND, dotted)
and gastric bypass (RYGB, striped)
surgery. (B,D,F,H and J) change in
levels after ice cream meal (ΔAUC
+150 to +210 min) in surgical groups.
Data are presented as mean±SEM.
###p<0.005 versus BMI-M; *p<0.05,
***p<0.005 versus BAND; n=20–21
per group.
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Figure 6 Eating behaviour. (A) EDE-Q dietary restraint, (B) DEBQ dietary restraint, (C) DEBQ external eating, (D) DEBQ emotional eating and EDE-
Q (E) weight concerns, (F) shape concerns, (G) eating concerns and (H) global score of body mass index-matched unoperated controls (BMI-M,
white) and obese patients after gastric banding (BAND, dotted) and gastric bypass (RYGB, striped) surgery. Data are presented as (A and G) median
and IQR, or (B,C–F and H) mean±SEM. #p<0.05, ###p<0.005 versus BMI-M; *p<0.05, **p<0.01 versus BAND; n=20–21 per group. DEBQ: Dutch
Eating Behaviour Questionnaire, EDE-Q: Eating Disorders Examination Questionnaire.
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Figure 7 Plasma levels of gut hormones and bile acids in obese patients after gastric bypass and gastric banding and controls. Comparison of (A,
C and E) plasma hormone levels (GLP-1, peptide YY, acyl ghrelin, area under curve (AUC) +40 to +150 min) and (G) total bile acid levels during
fMRI scan (AUC +70 to +150 min) between body mass index-matched unoperated controls (BMI-M, white) and obese patients after gastric banding
(BAND, dotted) and gastric bypass (RYGB, striped) surgery. Comparison of (B,D and F) change in plasma hormone levels and (H) change in total bile
acid levels after ice cream meal (both ΔAUC +150 to +210 min) between two surgical groups. Data are presented as median and IQR. ##p<0.01
versus BMI-M; *p<0.05, ***p<0.005 versus BAND; n=20–21 per group.
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ratings of the high-calorie ice cream lunch in the RYGB group
(Pearson r=+0.49, p=0.029), and a similar trend was seen in
the BAND group (r=+0.45, p=0.055).
However, within the RYGB group, there was no signiﬁcant cor-
relation between BOLD activation to any food, or high-calorie or
low-calorie food pictures in the whole reward system, OFC or
amygdala with any of the following secondary outcome mea-
sures: GLP-1, PYY or total bile acids area under curve (AUC)
during fMRI scan (correlation coefﬁcient −0.35 to +0.31,
p=0.13–0.92); absolute GLP-1, PYYor total bile acids AUC after
ice cream meal (−0.24 to +0.29, p=0.22–1.0); or either of the
dumping questionnaire scores (−0.39 to +0.27, p=0.11–1.0).
DISCUSSION
This study has demonstrated that obese patients after RYGB
have a markedly different brain-hedonic response to food com-
pared with BAND surgery. The primary ﬁnding was that
patients after RYGB had lower activation in several brain regions
to food, especially high-calorie, including the OFC, amygdala,
caudate nucleus, nucleus accumbens and hippocampus. These
differences in brain reward systems were accompanied by beneﬁ-
cial differences in dietary behaviour and food hedonics, as seen
from the secondary outcomes. After RYGB, patients consumed
proportionately less dietary fat, found sweet, high-fat food less
palatable, rated high-calorie foods as less appealing and had
healthier eating behaviour than after BAND surgery. These dif-
ferences were unrelated to differences in hunger or psycho-
logical traits between the surgical groups. The identiﬁcation of
these phenotypic differences provides a novel explanation for
the more favourable long-term weight loss seen after RYGB
than BAND surgery, with important clinical and pathophysio-
logical implications.
Our ﬁnding of lower reward system activation to food pictures
in the RYGB group is consistent with reduced food hedonics and
consummatory behaviour. Lower neural responses to food cues
in these brain regions are seen in the fed state 14–16 and are asso-
ciated with decreased appeal of high-calorie food pictures,16
ﬁnding high-calorie foods such as ice cream less palatable (as
seen in our study), sensory-speciﬁc satiety,17 18 deliberate inhib-
ition of the desire for pleasant foods,19 lower prospective food
consumption,20 less longitudinal weight gain21 22 and greater
success in a lifestyle weight loss programme.23
Although some fMRI studies have shown greater activation in
these regions to viewing high-calorie foods, or anticipation of
food delivery, in people with obesity, higher BMI, or BED, results
have been inconsistent and even contradictory.24 25 Nevertheless,
the inclusion of a lean, rather than BMI-matched control group
in our study may have been helpful, to assess whether the magni-
tude of the reward system responses in the RYGB group are
similar to those of never-obese healthy subjects.
The neuroimaging ﬁndings in this cross-sectional study in
RYGB patients are consistent with prospective human studies of
RYGB.2 A prospective fMRI study found correlations between
reduced food wanting and reduced brain activation, including
caudate, frontal gyri and anterior cingulate cortex, to high-
calorie food in the ﬁrst month after RYGB.26 This smaller study
did not, however, control for order effects, changes in BMI or
for the early postoperative dietary restrictions. By contrast, in
our study, the comparison with BAND patients avoided order
effects and controlled for BMI differences, and all scanning
took place at least 3 months after surgery, after liquid diet
restrictions had ended.
The secondary behavioural outcomes were also in agreement
with prospective animal and human studies of RYGB. Animal
models of RYGB show a reduced preference for sweet and/or
fatty stimuli compared with sham-operated animals.9 27 Obese
patients work less hard in a progressive ratio task for sweet/fatty
taste stimuli after RYGB than preoperatively.8 Longitudinal
shifts away from a calorie-dense diet have also been described
after RYGB.28
Metabolic phenotyping results point to potential mediators
behind these differences in food hedonic responses, although
direct causal inference has not been established. As expected,
postprandial plasma GLP-1 and PYY gut hormone levels, and
prelunch PYY levels, were higher in this cohort after RYGB than
BAND and/or unoperated groups.5 In addition to increasing
satiety through homeostatic appetite centres (vagal–brainstem–
hypothalamic), these hormones also modify activity in brain
reward systems and dopaminergic signalling.29 30 GLP-1 and/or
PYYacutely reduce BOLD signal to visual food cues in non-obese
subjects in similar brain regions to our study,31 mediate changes
in taste away from high-fat, sweet foods32 and plasma levels cor-
relate with longitudinal reductions in uncontrolled eating after
RYGB.33 Brain hedonic-reward systems may therefore respond
not only acutely but also to chronic exposure to the repeated
exaggerated postprandial increases in GLP-1 and PYY.34
Figure 8 Assessment of dumping syndrome in surgical groups.
Comparison of retrospective (A) Sigstad’s and (B) Arts’ dumping
syndrome scores during ﬁrst 3 months after surgery (n=18–19 per
group), between obese patients after gastric banding (BAND, dotted)
and gastric bypass (RYGB, striped) surgery. Data are presented as
median and IQR. *p<0.05, ***p<0.005 versus BAND.
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Plasma bile acids were also higher in the RYGB than BAND
group, not only postprandially but also before lunch.35 This
could be an alternative modulator of central hedonic processing
of food after RYGB. Indeed, bile acids cross the blood–brain
barrier,36 and the bile acid receptor TGR5 is present in the
brain.37 Bile acids also stimulate small bowel production of
ﬁbroblast growth factor 19 (FGF19), which reduces food intake
centrally,38 and increases after RYGB.35 A direct role for bile
acids or FGF19 after RYGB may therefore be worthy of further
exploration.
RYGB patients also reported greater prevalence of symptoms
consistent with dumping syndrome in the early postoperative
period, and were more nauseated after ingestion of the high-
calorie test meal, than after BAND surgery. Learned conditioned
aversion due to postingestive effects of high-calorie foods may
also therefore play a role in the reduced food hedonic responses
after RYGB, potentially mediated by changes in GLP-1 and PYY.9
Although the orexigenic hormone ghrelin has stimulatory
effects on food hedonics and reward system activation to food
cues,29 we did not ﬁnd any signiﬁcant difference in plasma acyl
ghrelin between surgical groups. Some studies have found
reduced fasting and/or postprandial ghrelin levels after RYGB
compared with before surgery or unoperated controls. This
ﬁnding is, however, not universal, related to differences in surgi-
cal techniques, assay of total versus active acyl ghrelin, problems
with handling and storage of plasma samples.2
It was not possible to further clarify which of these potential
mediators might contribute to the reduced brain-hedonic
response to food after RYGB, as within the RYGB group, none
were correlated with BOLD activation to food cues (in those
ROIs that displayed differences between surgical groups). The
ability to detect such an association may have been hindered by
the sample size, cross-sectional nature of the study and other
physiological factors contributing to the variability in BOLD
responses between individuals within the group.39
Although our study was cross-sectional, preoperative and
postoperative confounding variables were generally similar
between surgical groups, including the prevalence of BED and
current T2DM. Although weight loss was greater in the RYGB
patients than in the BMI-matched BAND patients, this is
unlikely to explain our ﬁndings, since this would be anticipated
to increase reward responses to food cues.40 Patient allocation
to surgery was not randomised. Nevertheless, the choice of sur-
gical procedure is not inﬂuenced by preoperative food hedonics.
If anything, patients who chose RYGB tended to be heavier pre-
operatively and therefore less likely to have healthier food hedo-
nics than BAND patients.
Our sample size of scanned subjects is comparable with other
fMRI studies investigating food reward10 31 and phenotyping
studies after bariatric surgery,5 but there were a large number of
outcome measures that were not corrected for multiple compar-
isons. We cannot, however, exclude the possibility that type 1 or
2 errors may have occurred for some results. Nevertheless,
several complimentary behavioural measures showed results in
the same direction as the primary fMRI endpoint.
We were surprised not to observe lower consumption of ice
cream in the RYGB compared with BAND group. A possible
explanation is that the test meal was not speciﬁcally designed to
examine food preference, as subjects were not given a choice of
foods of different caloric density. Analysis of macronutrient
intake outside of the laboratory did reveal lower fat intake after
RYGB compared with BAND surgery.
Our results have revealed novel differences in food reward
and hedonics between these surgical treatments of obesity. This
may prompt the development of more personalised approaches
to surgical choices that incorporate preoperative assessment of
food preference and craving. Other factors inﬂuencing the
choice of bariatric procedure include local expertise and patient
preference. There are potentially greater improvements in gly-
caemic control after RYGB,3 35 contrasting with shorter oper-
ation time and hospital stay, lower cost and lower mortality
rates with BAND surgery.41 However, in appropriately experi-
enced centres, absolute mortality rates are less than 0.3% for
either procedure.41
In conclusion, RYGB and BAND surgical treatments for
obesity are distinct in their mechanisms of weight loss.
Postoperatively patients have reduced hunger after both proce-
dures, but there are lower brain hedonic and exaggerated gut
hormone and bile acid responses to food after RYGB that would
explain its greater efﬁcacy for weight loss. This implicates the
gut–brain axis in regulating reward-driven eating behaviour as
well as homeostatic appetite, and hence, body weight. Further
in-depth interrogation of these gut–brain mechanisms will accel-
erate development of efﬁcacious, cheaper and safer non-surgical
treatments for hedonic overeating and obesity.
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